Works matching IS 15330028 AND DT 2014 AND VI 13 AND IP 2


Results: 9
    1
    2
    3

    Personalized Dosing via Pharmacokinetic Monitoring of 5-Fluorouracil Might Reduce Toxicity in Early- or Late-Stage Colorectal Cancer Patients Treated With Infusional 5-Fluorouracil-Based Chemotherapy Regimens.

    Published in:
    Clinical Colorectal Cancer, 2014, v. 13, n. 2, p. 119, doi. 10.1016/j.clcc.2013.11.001
    By:
    • Kline, Christina Leah B.;
    • Schiccitano, Angelique;
    • Junjia Zhu;
    • Beachler, Cheryl;
    • Sheikh, Hassan;
    • Harvey, Harold A.;
    • Mackley, Heath B.;
    • McKenna, Kevin;
    • Staveley-O'Carroll, Kevin;
    • Poritz, Lisa;
    • Messaris, Evangelos;
    • Stewart, David;
    • Sivik, Jeffrey;
    • El-Deiry, Wafik S.
    Publication type:
    Article
    4
    5

    Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147.

    Published in:
    Clinical Colorectal Cancer, 2014, v. 13, n. 2, p. 100, doi. 10.1016/j.clcc.2013.12.002
    By:
    • Huang, Jocelin;
    • Nair, Suresh G.;
    • Mahoney, Michelle R.;
    • Nelson, Garth D.;
    • Shields, Anthony F.;
    • Ghan, Emily;
    • Goldberg, Richard M.;
    • Gill, Sharlene;
    • Kahlenberg, Morton S.;
    • Quesenberry, James T.;
    • Thibodeau, Stephen N.;
    • Smyrk, Thomas G.;
    • Grothey, Axel;
    • Sinicrope, Frank A.;
    • Webb, Thomas A.;
    • Farr Jr, Gist H.;
    • Pockaj, Barbara A.;
    • Berenberg, Jeffrey L.;
    • Mooney, Margaret;
    • Sargent, Daniel J.
    Publication type:
    Article
    6
    7
    8
    9